Pressure points: Risk management in the pharmaceuticals industry
by KPMG International
The link between risk and reward has never been more important than it is now in the pharmaceuticals industry as it grapples with the challenges of delivering profitable, new solutions for better health care in the global marketplace. Boards and management are looking to better understand, anticipate and mitigate business risk in order to deliver the rewards of risk taking, and to minimize the frequency and impact of risk on the downside. This white paper from KPMG puts forward ideas on how risk management can be improved, presenting the view that the business-as-usual attitude may fail.
KPMG believes companies must be more proactive in their efforts to manage risk on an enterprisewide basis. This will help them comply with corporate governance requirements and help their presentation to bond-ratings agencies, which are now examining the effectiveness of governance, including risk-management processes.
| Published: | 2005 |
| Format: | |
| Length: | 24 pages |
| Type: | White paper |
| Language: | English |
.
SPONSORED REPORTS
